InvestorsObserver
×
News Home

Haemonetics Corporation (HAE) has risen 12.24% in a Week, Should You Buy?

Tuesday, May 10, 2022 10:24 AM | InvestorsObserver Analysts

Mentioned in this article

Haemonetics Corporation (HAE) has risen 12.24% in a Week, Should You Buy?

A rating of 81 puts Haemonetics Corporation (HAE) near the top of the Medical Instruments & Supplies industry according to InvestorsObserver. Haemonetics Corporation's score of 81 means it scores higher than 81% of stocks in the industry. Haemonetics Corporation also received an overall rating of 57, putting it above 57% of all stocks. Medical Instruments & Supplies is ranked 101 out of the 148 industries.

Overall Score - 57
HAE has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on HAE!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Haemonetics Corporation Stock Today?

Haemonetics Corporation (HAE) stock is trading at $56.58 as of 10:23 AM on Tuesday, May 10, a rise of $7.31, or 14.84% from the previous closing price of $49.27. The stock has traded between $51.17 and $58.39 so far today. Volume today is below average. So far 147,707 shares have traded compared to average volume of 489,751 shares. Click Here to get the full Stock Report for Haemonetics Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App